Safety of Simultaneous Hepatectomy and Splenectomy in the Treatment of Hepatocellular Carcinoma Complicated with Hypersplenism: A Meta-analysis.

Xue-Feng LiuZhiqiang ChenMeng YuWei ZhouXuting Zhi Tao Li

Published in: Gastroenterology research and practice (2019)

Compared to HA, HS is safer and more effective in ameliorating liver function and improving survival of HCC patients complicated with hypersplenism. This trial is registered with CRD42018093779.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
ejection fraction
clinical trial
peritoneal dialysis
prognostic factors
phase iii
patient reported outcomes
phase ii
combination therapy
free survival